Shearman And Sterling

Event April 23 - 25, 2018

Pharmaceutical Compliance Congress U.S.

  • Washington, DC

Global Compliance partner Brian Burke spoke on the “Global Compliance ― Emerging Markets and Third-Party Due Diligence” panel at the Pharmaceutical Compliance Congress in Washington, D.C. on April 24, 2018.

Other industry thought leaders participating on this panel included:

  • David Styler
    Head, Global Compliance Governance and Investigations
    Takeda Pharmaceuticals
  • Gildas Durand
    Principal, Fraud Investigations & Dispute Services
    Ernst & Young LLP
  • Richard Wright
    Vice President, Global Head of Compliance Audit
    Teva Pharmaceuticals

Discussion topics included:

  • Assess how vendors are interacting, in the marketplace, on your behalf
  • Navigate the specialty marketplace and educate third parties on the complexities of marketing, selling and distributing these products
  • Review strategies for effective oversight, both locally and globally
  • Identify controls to minimize risk through distributors, high-risk parties and complex business transactions
  • Monitor relationships with specialty pharmacies and distributors
  • Ensure third parties remain compliant
  • Assess what controls should be in place
  • Discuss strategies for ensuring contracting compliance
  • Examine sub-distributors, auditing facilities and audit provisions



Regional Experience